| - GRCh37:
- Chr16:51173528
- GRCh38:
- Chr16:51139617
| SALL1 | Q772E, Q869E | Townes-Brocks syndrome 1 | Uncertain significance (Mar 6, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51176029
- GRCh38:
- Chr16:51142118
| SALL1 | R35L | Townes-Brocks syndrome 1 | Uncertain significance (Oct 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51173864
- GRCh38:
- Chr16:51139953
| SALL1 | R660C, R757C | Townes syndrome, Townes-Brocks syndrome 1 | Uncertain significance (Mar 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175300
- GRCh38:
- Chr16:51141389
| SALL1 | S181F, S278F | Townes-Brocks syndrome 1 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr16:51174905
- GRCh38:
- Chr16:51140994
| SALL1 | G313*, G410* | Townes-Brocks syndrome 1 | Pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51174004
- GRCh38:
- Chr16:51140093
| SALL1 | I613fs, I710fs | Townes-Brocks syndrome 1 | Likely pathogenic (Aug 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172811
- GRCh38:
- Chr16:51138900
| SALL1 | V1011F, V1108F | Townes-Brocks syndrome 1 | Uncertain significance (May 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51174355
- GRCh38:
- Chr16:51140444
| SALL1 | S496N, S593N | Townes-Brocks syndrome 1 | Uncertain significance (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51175424
- GRCh38:
- Chr16:51141513
| SALL1 | Q140*, Q237* | Townes-Brocks syndrome 1 | Pathogenic (Jun 3, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr16:51175412
- GRCh38:
- Chr16:51141501
| SALL1 | I144V, I241V | Townes-Brocks syndrome 1 | Uncertain significance (Feb 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51175639
- GRCh38:
- Chr16:51141728
| SALL1 | S165F, S68F | Townes-Brocks syndrome 1 | Uncertain significance (Jun 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51174764-51174770
- GRCh38:
- Chr16:51140853-51140859
| SALL1 | | Townes-Brocks syndrome 1 | Pathogenic (Aug 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51175532
- GRCh38:
- Chr16:51141621
| SALL1 | Q104*, Q201* | Townes-Brocks syndrome 1 | Pathogenic/Likely pathogenic (Aug 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51174358
- GRCh38:
- Chr16:51140447
| SALL1 | K495R, K592R | Townes-Brocks syndrome 1 | Uncertain significance (Aug 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51174180
- GRCh38:
- Chr16:51140269
| SALL1 | | Townes syndrome, Townes-Brocks syndrome 1 | Likely benign (Sep 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175515
- GRCh38:
- Chr16:51141604
| SALL1 | | Townes syndrome, Townes-Brocks syndrome 1 | Likely benign (May 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173568
- GRCh38:
- Chr16:51139657
| SALL1 | | Townes syndrome, Townes-Brocks syndrome 1 | Likely benign (Mar 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172902
- GRCh38:
- Chr16:51138991
| SALL1 | | Townes syndrome, Townes-Brocks syndrome 1 | Likely benign (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173281
- GRCh38:
- Chr16:51139370
| SALL1 | A951V, A854V | Townes syndrome, Townes-Brocks syndrome 1 | Uncertain significance (Apr 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51174906
- GRCh38:
- Chr16:51140995
| SALL1 | | Townes syndrome, Townes-Brocks syndrome 1 | Likely benign (May 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171270
- GRCh38:
- Chr16:51137359
| SALL1 | N1146S, N1243S | Townes-Brocks syndrome 1, Townes syndrome | Uncertain significance (May 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173176
- GRCh38:
- Chr16:51139265
| SALL1 | L889S, L986S | Townes-Brocks syndrome 1, Townes syndrome | Uncertain significance (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173186
- GRCh38:
- Chr16:51139275
| SALL1 | E886Q, E983Q | Townes syndrome, Townes-Brocks syndrome 1 | Uncertain significance (Feb 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172752
- GRCh38:
- Chr16:51138841
| SALL1 | R1031fs, R1128fs | Townes-Brocks syndrome 1 | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51173195
- GRCh38:
- Chr16:51139284
| SALL1 | I883F, I980F | Townes-Brocks syndrome 1, not provided | Uncertain significance (May 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171367
- GRCh38:
- Chr16:51137456
| SALL1 | V1114F, V1211F | Townes-Brocks syndrome 1, not provided | Uncertain significance (Nov 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175117
- GRCh38:
- Chr16:51141206
| SALL1 | P242L, P339L | Townes-Brocks syndrome 1, not provided | Uncertain significance (Mar 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171216
- GRCh38:
- Chr16:51137305
| SALL1 | P1164R, P1261R | Townes-Brocks syndrome 1, not provided | Uncertain significance (Dec 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175914
- GRCh38:
- Chr16:51142003
| SALL1 | | not provided, Townes syndrome, Townes-Brocks syndrome 1
| Benign/Likely benign (Sep 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172823
- GRCh38:
- Chr16:51138912
| SALL1 | P1007A, P1104A | Townes syndrome, not provided, Townes-Brocks syndrome 1
| Benign/Likely benign (Oct 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51174568
- GRCh38:
- Chr16:51140657
| SALL1 | T425M, T522M | not provided, Townes-Brocks syndrome 1 | Benign/Likely benign (Jan 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173802
- GRCh38:
- Chr16:51139891
| SALL1 | | Townes syndrome, not provided, Townes-Brocks syndrome 1
| Benign/Likely benign (May 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171269
- GRCh38:
- Chr16:51137358
| SALL1 | | Townes syndrome, not provided, Townes-Brocks syndrome 1
| Benign/Likely benign (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51174926
- GRCh38:
- Chr16:51141015
| SALL1 | P306S, P403S | not provided, Townes-Brocks syndrome 1 | Uncertain significance (Aug 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173874
- GRCh38:
- Chr16:51139963
| SALL1 | | Townes-Brocks syndrome 1, not provided | Likely benign (Dec 20, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172803
- GRCh38:
- Chr16:51138892
| SALL1 | | not provided, Townes-Brocks syndrome 1 | Likely benign (Dec 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175709
- GRCh38:
- Chr16:51141798
| SALL1 | G142R, G45R | Townes-Brocks syndrome 1 | Uncertain significance (Jul 10, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51174374
- GRCh38:
- Chr16:51140463
| SALL1 | P490T, P587T | Townes-Brocks syndrome 1 | Uncertain significance (Jan 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51175863-51175864
- GRCh38:
- Chr16:51141952-51141953
| SALL1 | P91fs | Townes-Brocks syndrome 1 | Likely pathogenic (Mar 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51173045
- GRCh38:
- Chr16:51139134
| SALL1 | I1030V, I933V | Townes syndrome, Townes-Brocks syndrome 1 | Uncertain significance (Jan 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173287
- GRCh38:
- Chr16:51139376
| SALL1 | Q852R, Q949R | Townes-Brocks syndrome 1 | Uncertain significance (Jun 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51174767-51174768
- GRCh38:
- Chr16:51140856-51140857
| SALL1 | K359fs, K456fs | Townes-Brocks syndrome 1 | Pathogenic (Jul 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171216
- GRCh38:
- Chr16:51137305
| SALL1 | P1164L, P1261L | Townes-Brocks syndrome 1 | Uncertain significance (Aug 26, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171151
- GRCh38:
- Chr16:51137240
| SALL1 | E1186K, E1283K | Townes-Brocks syndrome 1 | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51174260
- GRCh38:
- Chr16:51140349
| SALL1 | E528*, E625* | Townes-Brocks syndrome 1 | Pathogenic (Jul 23, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171211
- GRCh38:
- Chr16:51137300
| SALL1 | I1166V, I1263V | Townes-Brocks syndrome 1 | Uncertain significance (Aug 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175721
- GRCh38:
- Chr16:51141810
| SALL1 | G41S, G138S | Townes syndrome, not provided, Townes-Brocks syndrome 1
| Conflicting interpretations of pathogenicity (Dec 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51173845-51173846
- GRCh38:
- Chr16:51139934-51139935
| SALL1 | R666fs, R763fs | Townes-Brocks syndrome 1 | Likely pathogenic (Oct 4, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr16:51174083
- GRCh38:
- Chr16:51140172
| SALL1 | Q587*, Q684* | Townes-Brocks syndrome 1 | Uncertain significance (Feb 7, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51171162
- GRCh38:
- Chr16:51137251
| SALL1 | T1182M, T1279M | Inborn genetic diseases, Townes syndrome, not provided
| Uncertain significance (Mar 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173332
- GRCh38:
- Chr16:51139421
| SALL1 | S837fs, S934fs | Townes-Brocks syndrome 1 | Likely pathogenic (Aug 13, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr16:51173443-51173444
- GRCh38:
- Chr16:51139532-51139533
| SALL1 | V897fs, V800fs | Townes-Brocks syndrome 1 | Pathogenic (Aug 10, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51175430
- GRCh38:
- Chr16:51141519
| SALL1 | A235T, A138T | not provided, Townes-Brocks syndrome 1 | Conflicting interpretations of pathogenicity (May 28, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51173049
- GRCh38:
- Chr16:51139138
| SALL1 | | not provided, Townes-Brocks syndrome 1 | Likely benign (Aug 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175655-51175656
- GRCh38:
- Chr16:51141744-51141745
| SALL1 | | Townes-Brocks syndrome 1, Townes syndrome, not provided
| Benign/Likely benign (Oct 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51174619
- GRCh38:
- Chr16:51140708
| SALL1 | H408R, H505R | Townes-Brocks syndrome 1 | Uncertain significance (Aug 4, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172811
- GRCh38:
- Chr16:51138900
| SALL1 | V1011I, V1108I | not specified, Townes-Brocks syndrome 1 | Likely benign (Dec 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175585
- GRCh38:
- Chr16:51141674
| SALL1 | T183K, T86K | Townes-Brocks syndrome 1, Townes syndrome | Conflicting interpretations of pathogenicity (Jul 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51175531
- GRCh38:
- Chr16:51141620
| SALL1 | Q201R, Q104R | not provided, VACTERL with hydrocephalus, Townes-Brocks syndrome 1
| Uncertain significance (Mar 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175869
- GRCh38:
- Chr16:51141958
| SALL1 | | not provided, Townes syndrome, Townes-Brocks syndrome 1
| Benign/Likely benign (Aug 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175655-51175656
- GRCh38:
- Chr16:51141744-51141745
| SALL1 | | not provided, Townes-Brocks syndrome 1 | Uncertain significance (Mar 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175746
- GRCh38:
- Chr16:51141835
| SALL1 | | Townes syndrome, Townes-Brocks syndrome 1, not specified
| Likely benign (Oct 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175772
- GRCh38:
- Chr16:51141861
| SALL1 | R121G, R24G | not provided, Townes-Brocks syndrome 1 | Uncertain significance (Jul 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173855
- GRCh38:
- Chr16:51139944
| SALL1 | P760S, P663S | not provided, Townes-Brocks syndrome 1 | Uncertain significance (Apr 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172953
- GRCh38:
- Chr16:51139042
| SALL1 | | Townes syndrome, not specified, not provided, Townes-Brocks syndrome 1 | Benign/Likely benign (Sep 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172934
- GRCh38:
- Chr16:51139023
| SALL1 | L1067F, L970F | Townes-Brocks syndrome 1, Townes syndrome | Conflicting interpretations of pathogenicity (Jul 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51175024-51175025
- GRCh38:
- Chr16:51141113-51141114
| SALL1 | V273fs, V370fs | Townes-Brocks syndrome 1 | Pathogenic (Apr 26, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51172718-51172719
- GRCh38:
- Chr16:51138807-51138808
| SALL1 | C1042fs, C1139fs | not provided, Townes-Brocks syndrome 1, Townes syndrome
| Pathogenic (Jul 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171227
- GRCh38:
- Chr16:51137316
| SALL1 | | not specified, Townes syndrome, Townes-Brocks syndrome 1
| Likely benign (Feb 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51185110
- GRCh38:
- Chr16:51151199
| SALL1 | D15N | Townes-Brocks syndrome 1 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51175782
- GRCh38:
- Chr16:51141871
| SALL1 | | Townes syndrome, Townes-Brocks syndrome 1, not provided
| Likely benign (Sep 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175655-51175656
- GRCh38:
- Chr16:51141744-51141745
| SALL1 | | not provided, Townes syndrome, not specified, Townes-Brocks syndrome 1 | Conflicting interpretations of pathogenicity (Oct 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51175596
- GRCh38:
- Chr16:51141685
| SALL1 | | Townes syndrome, not provided, Townes-Brocks syndrome 1
| Benign/Likely benign (Oct 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172911
- GRCh38:
- Chr16:51139000
| SALL1 | | Townes syndrome, not provided, Townes-Brocks syndrome 1
| Benign/Likely benign (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171056
- GRCh38:
- Chr16:51137145
| SALL1 | | not provided, not specified, Townes-Brocks syndrome 1, Townes syndrome | Benign/Likely benign (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51170931-51170935
- GRCh38:
- Chr16:51137020-51137024
| SALL1 | | Townes-Brocks syndrome 1, not provided | Likely benign (Mar 31, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51170460
- GRCh38:
- Chr16:51136549
| SALL1 | | Townes-Brocks syndrome 1 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51170435
- GRCh38:
- Chr16:51136524
| SALL1 | | Townes-Brocks syndrome 1 | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51170317-51170318
- GRCh38:
- Chr16:51136406-51136407
| SALL1 | | Townes-Brocks syndrome 1 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51170095-51170097
- GRCh38:
- Chr16:51136184-51136186
| SALL1 | | not provided, Townes-Brocks syndrome 1 | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51169989-51169990
- GRCh38:
- Chr16:51136078-51136079
| SALL1 | | Townes-Brocks syndrome 1 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51169910-51169911
- GRCh38:
- Chr16:51135999-51136000
| SALL1 | | Townes-Brocks syndrome 1 | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:51175649
- GRCh38:
- Chr16:51141738
| SALL1 | G162S, G65S | not provided, Townes-Brocks syndrome 1, Townes syndrome
| Uncertain significance (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51174804
- GRCh38:
- Chr16:51140893
| SALL1 | D443E, D346E | not provided, Townes-Brocks syndrome 1 | Uncertain significance (Feb 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171204
- GRCh38:
- Chr16:51137293
| SALL1 | G1265E, G1168E | Townes syndrome, not specified, not provided, Townes-Brocks syndrome 1 | Benign/Likely benign (Sep 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175643-51175644
- GRCh38:
- Chr16:51141732-51141733
| SALL1 | | not specified, Townes syndrome, not provided, Townes-Brocks syndrome 1 | Conflicting interpretations of pathogenicity (Jul 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51175658
- GRCh38:
- Chr16:51141747
| SALL1 | S159G, S62G | not provided, not specified, Townes syndrome, Townes-Brocks syndrome 1 | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175655-51175656
- GRCh38:
- Chr16:51141744-51141745
| SALL1 | | not specified, not provided, Townes syndrome, Townes-Brocks syndrome 1 | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171175
- GRCh38:
- Chr16:51137264
| SALL1 | V1275I, V1178I | not provided, not specified, Townes syndrome, Townes-Brocks syndrome 1 | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51172677
- GRCh38:
- Chr16:51138766
| SALL1 | | Townes syndrome, not provided, Townes-Brocks syndrome 1, not specified | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173559
- GRCh38:
- Chr16:51139648
| SALL1 | | not provided, not specified, Townes syndrome, Townes-Brocks syndrome 1 | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175656-51175664
- GRCh38:
- Chr16:51141745-51141753
| SALL1 | | not specified, Townes-Brocks syndrome 1, not provided, Townes syndrome | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51176003
- GRCh38:
- Chr16:51142092
| SALL1 | V44I | not provided, Townes-Brocks syndrome 1 | Conflicting interpretations of pathogenicity (Dec 19, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51172973
- GRCh38:
- Chr16:51139062
| SALL1 | R1054*, R957* | Townes syndrome, not provided | Pathogenic/Likely pathogenic (Nov 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51171126
- GRCh38:
- Chr16:51137215
| SALL1 | N1291S, N1194S | Townes syndrome, not specified, not provided, Townes-Brocks syndrome 1 | Benign/Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175184
- GRCh38:
- Chr16:51141273
| SALL1 | P317S, P220S | not provided, Townes-Brocks syndrome 1 | Conflicting interpretations of pathogenicity (Apr 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51173013
- GRCh38:
- Chr16:51139102
| SALL1 | | not specified, not provided, Townes syndrome, Townes-Brocks syndrome 1 | Benign/Likely benign (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51173850
- GRCh38:
- Chr16:51139939
| SALL1 | | not provided, Townes-Brocks syndrome 1 | Uncertain significance (Jan 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:51175656-51175658
- GRCh38:
- Chr16:51141745-51141747
| SALL1 | S159del, S62del | Townes syndrome, not specified, not provided, Townes-Brocks syndrome 1 | Conflicting interpretations of pathogenicity (Oct 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:51175138
- GRCh38:
- Chr16:51141227
| SALL1 | P235fs, P332fs | Townes-Brocks syndrome 1 | Pathogenic (Dec 15, 2007) | no assertion criteria provided |